Johnson & Johnson (NYSE:JNJ) is one of the stocks Jim Cramer picked for his fantasy stock portfolio. Cramer made some positive comments about the company, as he commented: “JNJ’s up roughly 23% year to date. I couldn’t believe it, I saw it was like 180. It was amazing. Weak action throughout most of the healthcare, not affecting these people. Their core pharma business is roaring. Terrific oncology franchise, medical devices really strong now. That’s why JNJ keeps putting up good numbers, and they don’t h ...